ATE109014T1 - Automatische injektionseinrichtung. - Google Patents

Automatische injektionseinrichtung.

Info

Publication number
ATE109014T1
ATE109014T1 AT85902879T AT85902879T ATE109014T1 AT E109014 T1 ATE109014 T1 AT E109014T1 AT 85902879 T AT85902879 T AT 85902879T AT 85902879 T AT85902879 T AT 85902879T AT E109014 T1 ATE109014 T1 AT E109014T1
Authority
AT
Austria
Prior art keywords
injection
blood flow
muscle tissue
patient
received
Prior art date
Application number
AT85902879T
Other languages
English (en)
Inventor
Jay Stanley Sarnoff
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/638,695 external-priority patent/US4658830A/en
Priority claimed from US06/708,845 external-priority patent/US4661469A/en
Application filed by Survival Technology filed Critical Survival Technology
Application granted granted Critical
Publication of ATE109014T1 publication Critical patent/ATE109014T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/02Ammonia; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2066Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically comprising means for injection of two or more media, e.g. by mixing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y115/00Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001Superoxide dismutase (1.15.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21068Tissue plasminogen activator (3.4.21.68), i.e. tPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M2005/1787Syringes for sequential delivery of fluids, e.g. first medicament and then flushing liquid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/206With automatic needle insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2073Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/19Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/3756Casings with electrodes thereon, e.g. leadless stimulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Catching Or Destruction (AREA)
AT85902879T 1984-08-08 1985-05-29 Automatische injektionseinrichtung. ATE109014T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/638,695 US4658830A (en) 1984-08-08 1984-08-08 Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
US06/708,845 US4661469A (en) 1984-08-08 1985-03-06 t-PA composition capable of being absorbed into the blood stream and method of administration
US06/735,311 US4832682A (en) 1984-08-08 1985-05-20 Injection method and apparatus with electrical blood absorbing stimulation

Publications (1)

Publication Number Publication Date
ATE109014T1 true ATE109014T1 (de) 1994-08-15

Family

ID=27417625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85902879T ATE109014T1 (de) 1984-08-08 1985-05-29 Automatische injektionseinrichtung.

Country Status (9)

Country Link
US (1) US4832682A (de)
EP (1) EP0191771B1 (de)
JP (1) JPH0613051B2 (de)
AT (1) ATE109014T1 (de)
AU (1) AU591871B2 (de)
CA (1) CA1274140A (de)
DE (1) DE3587892T2 (de)
IL (1) IL75359A (de)
WO (1) WO1986001120A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078680A (en) * 1984-08-08 1992-01-07 Survival Technology, Inc. Automatic injector for emergency treatment
US4689042A (en) * 1985-05-20 1987-08-25 Survival Technology, Inc. Automatic medicament ingredient mixing and injecting apparatus
DE3806562A1 (de) * 1988-03-01 1989-09-14 Alpha Therapeutic Gmbh Zweikammerspritze mit einer fuellung aus aktivitaetsempfindlichem humanen protein als wirkstoff
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd 3−デオキシグルコソン生成阻害剤
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
US6713291B2 (en) * 1999-01-28 2004-03-30 Alan D. King Electrodes coated with treating agent and uses thereof
WO2000044438A1 (en) * 1999-01-28 2000-08-03 Cyto Pulse Sciences, Inc. Delivery of macromolecules into cells
US6517517B1 (en) * 2000-06-08 2003-02-11 Mayo Foundation For Medical Education And Research Automated injection device for administration of liquid medicament
US6423050B1 (en) * 2000-06-16 2002-07-23 Zbylut J. Twardowski Method and apparatus for locking of central-vein catheters
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
AU2002327675A1 (en) * 2001-09-19 2003-04-01 Biovalve Technologies, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
US20030135166A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Switchable microneedle arrays and systems and methods relating to same
US6912417B1 (en) * 2002-04-05 2005-06-28 Ichor Medical Systmes, Inc. Method and apparatus for delivery of therapeutic agents
IL157981A (en) 2003-09-17 2014-01-30 Elcam Medical Agricultural Cooperative Ass Ltd Auto injector
SG136133A1 (en) 2004-03-08 2007-10-29 Ichor Medical Systems Inc Ca U Improved apparatus for electrically mediated delivery of therapeutic agents
IL160891A0 (en) 2004-03-16 2004-08-31 Auto-mix needle
US20050273054A1 (en) * 2004-06-03 2005-12-08 Florida Atlantic University Epinephrine auto-injector
US20090030364A1 (en) * 2005-02-04 2009-01-29 The Johns Hopkins University Electroporation gene therapy gun system
US8409141B2 (en) 2007-11-12 2013-04-02 Bang & Olufsen Medicom A/S Auto injector with automatic needle retraction
JP2013538643A (ja) * 2010-10-04 2013-10-17 ナーボマトリクス リミテッド 低インピーダンスの箇所を発見し、そこに電気的刺激を印加するための電極
US9643770B2 (en) 2012-12-03 2017-05-09 Mylan Inc. System and method for medicament storage, dispensing, and administration
US9179260B2 (en) 2012-12-03 2015-11-03 Mylan Inc. Medicament information system and method
US9692829B2 (en) 2012-12-03 2017-06-27 Mylan Inc. Medication delivery system and method
US20140155827A1 (en) 2012-12-03 2014-06-05 Mylan, Inc. Medicament information system and method
WO2016058009A2 (en) * 2014-10-06 2016-04-14 Aktivax Auto-injector
WO2017009284A1 (en) * 2015-07-10 2017-01-19 Alk-Abelló A/S An injector comprising a safety pin
IL296595A (en) 2016-03-28 2022-11-01 Ichor Medical Systems Inc Method and device for administering medical substances
US11167085B2 (en) 2016-06-15 2021-11-09 True Concepts Medical Technologies, Llc Syringe systems and methods for multi-stage fluid delivery
US9962489B2 (en) 2016-06-15 2018-05-08 True Concepts Medical Technologies, Llc Syringe systems and methods for multi-stage fluid delivery
AT519383B1 (de) * 2016-10-27 2018-09-15 Pharma Consult Gmbh Injektionsvorrichtung, insbesondere Autoinjektor, zur gleichzeitigen Abgabe von mehreren Medikamenten
EP3345637B1 (de) 2017-01-09 2020-03-18 Verily Life Sciences LLC Systeme und verfahren für am körper tragbare notfallarzneimittelinjektionsvorrichtungen
EP3565618A1 (de) * 2017-01-09 2019-11-13 Verily Life Sciences LLC Wearable-vorrichtung zur injektion von nichtflüssiger medikation
CN112165964B (zh) * 2018-05-29 2023-02-21 艾斯曲尔医疗公司 用于输出至少一种物质的输出设备和方法
US10842949B1 (en) 2020-07-30 2020-11-24 Benson Eric Wengreen Auto-injectors featuring medicine delivery assurance
US20230321354A1 (en) * 2020-09-08 2023-10-12 Emergent Product Development Gaithersburg Inc. Autoinjector for administration of medications
US20230009502A1 (en) * 2021-07-09 2023-01-12 Medtronic, Inc. Electrical contact for a medical device lead

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2771554A (en) * 1950-04-11 1956-11-20 Gratzl Kurt Impulse generator for medical use
NL106573C (de) * 1957-05-31
US3078850A (en) * 1960-08-26 1963-02-26 Imp Electronics Inc Electrochemotherapeutic cardiac device
US3380449A (en) * 1964-11-02 1968-04-30 Stanley J. Sarnoff Cartridge with burstable seal
US3364929A (en) * 1964-12-21 1968-01-23 Burroughs Wellcome Co Method for administering muscle relaxant drug
US3565080A (en) * 1964-12-21 1971-02-23 Burroughs Wellcome Co Neuromuscular block monitoring apparatus
US3391695A (en) * 1966-06-17 1968-07-09 Stanley J. Sarnoff Cartridge with reflexed burstable diaphragm
US3424155A (en) * 1968-01-24 1969-01-28 Stanley J Sarnoff Burstable diaphragm seal
BE755224A (fr) * 1969-08-25 1971-02-24 Philips Nv Seringue d'injection
US3807411A (en) * 1971-08-16 1974-04-30 Concept External cardiac pacer with separable generating and power-probe units
US3882863A (en) * 1973-08-01 1975-05-13 Survival Technology Hypodermic injection device having cannula covered with resilient sheath
US4031893A (en) * 1976-05-14 1977-06-28 Survival Technology, Inc. Hypodermic injection device having means for varying the medicament capacity thereof
US4103690A (en) * 1977-03-21 1978-08-01 Cordis Corporation Self-suturing cardiac pacer lead
US4178928A (en) * 1977-08-10 1979-12-18 Tischlinger Edward A Self injector
US4226235A (en) * 1979-01-25 1980-10-07 Survival Technology, Inc. Plural injecting device
US4394863A (en) * 1981-10-23 1983-07-26 Survival Technology, Inc. Automatic injector with cartridge having separate sequentially injectable medicaments
US4413991A (en) * 1982-03-18 1983-11-08 Schmitz John B Dual dose ampule
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms

Also Published As

Publication number Publication date
DE3587892T2 (de) 1994-11-10
JPH0613051B2 (ja) 1994-02-23
EP0191771B1 (de) 1994-07-27
CA1274140A (en) 1990-09-18
AU591871B2 (en) 1989-12-21
AU4438785A (en) 1986-03-07
DE3587892D1 (de) 1994-09-01
IL75359A (en) 1990-12-23
IL75359A0 (en) 1985-09-29
US4832682A (en) 1989-05-23
EP0191771A1 (de) 1986-08-27
EP0191771A4 (de) 1987-12-07
WO1986001120A1 (en) 1986-02-27
JPS61502865A (ja) 1986-12-11

Similar Documents

Publication Publication Date Title
ATE109014T1 (de) Automatische injektionseinrichtung.
EP0495531B1 (de) Gerät zur transkutanen Verabreichung von Heilmitteln
US6022368A (en) Acupuncture method and device
ATE287271T1 (de) Verwendung von vegf zur herstellung eines medikaments zur behandlung oder verhinderung der intimalen hyperplasie und verabreichungsgerät
EP0440333A3 (en) Dopamine agonists for treating type ii diabetes
Lo et al. The sedative effect of acupuncture
Svorad Changes in the topographical distribution of glycogen in the brain during animal hypnosis
Davies et al. Vascular effects of substance P change synaptic responsiveness of cat dorsal horn neurons
RU95118746A (ru) Способ лечения больных токсикоманиями
SU1156700A1 (ru) Способ лечени неврозов
RU2753120C1 (ru) Способ лечения больных с лимфостазом нижних конечностей
CN1087927C (zh) 偏瘫综合治疗仪
RU2341243C1 (ru) Способ массажа
RU2199357C1 (ru) Способ лечения миофасциальных болей
RU98123365A (ru) Способ лечения больных
RU2077311C1 (ru) Способ лечения хронического тонзиллита у детей
UA135598U (uk) Спосіб лікування і реабілітації хворих на артрози і періартрити
SU418194A1 (de)
RU2086226C1 (ru) Способ лечения рефлекторно-сосудистых синдромов при остеохондрозе
RU94030979A (ru) Способ лечения остеохондроза
SU1690789A1 (ru) Способ лечени заболеваний периферических сосудов конечностей
SU1130322A1 (ru) Способ лечени кардалгии
SU1438782A1 (ru) Способ рефлексотерапии
SU889012A1 (ru) Способ лечени подострых и хронических сосудистых заболеваний и заболеваний периферических нервов
SU874060A1 (ru) Способ лечени алкоголизма

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties